In high-risk ICU patients, empirical fluconazole did not appreciably improve clinical outcomes. Invasive candidiasis increases morbidity and mortality in patients who have prolonged ICU stays.

Causes other than fluconazole prophylaxis that might have ... Biomerieux Inc.), which allow for rapid Candida albicans identification through the blue staining of the colonies after 48 hours ...

Fosmanogepix is a first-in-class antifungal treatment candidate with a novel mechanism of action. It is available in intravenous and oral formulations and has been evaluated for efficacy and safety in ...

Candida auris (C. auris ... Resistance to the common antifungal drugs, like fluconazole, has been found in the majority of C. auris strains found in patients. This means that these drugs do ...

First discovered in Japan in 2009, Candida auris is a type of yeast that ... tested in China were resistant to the ...

Candida naturally resides on the skin and mucosal ... The preferred first-line option is fluconazole: Available as a tablet ...

Fluconazole 2mg/mL; soln for IV infusion ... All doses are once daily. Oropharyngeal candidiasis: 200mg on Day 1, then 100mg/day for at least 2 weeks. Esophageal candidiasis: 200mg on Day 1 ...

Vaginal candidiasis. Ebrahimy F, Dolatian M, Moatar F, et al. Comparison of the therapeutic effects of Garcin(®) and fluconazole on Candida vaginitis. Singapore Med J. 2015;56(10):567-572.

Considering taking supplements to treat vaginal candidiasis? Below is a list of common natural remedies used to treat or reduce the symptoms of vaginal candidiasis. Follow the links to read common ...

Fluconazole 10mg/mL, 40mg/mL; pwd for oral susp; orange flavor; contains sucrose. All doses are once daily. Oropharyngeal candidiasis: 200mg on Day 1, then 100mg/day for at least 2 weeks.

Candidiasis, likely affectionately known to you as thrush, is an infection caused by an overgrowth of a yeast called candida. It can show up in many in parts of the body, including the mouth ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial ...